trending Market Intelligence /marketintelligence/en/news-insights/trending/IN1MNWqY2NKXe7ml_i_fQQ2 content esgSubNav
In This List

Neovasc closes $5M stock offering to fund heart device development

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share


Neovasc closes $5M stock offering to fund heart device development

Neovasc Inc. closed an underwritten public offering of 11,111,111 common shares, priced at 45 cents each.

The Richmond, British Columbia-based medical-device maker raised $5 million in gross proceeds that will be used to develop and commercialize its heart devices Neovasc Reducer and Tiara.

Funds from the offering will also be used for general corporate and working capital purposes.

H.C. Wainwright & Co. served as the sole book-running manager for the offering.